Fukumi Kamada
Shizuoka, 4118777, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Novel CYP2A7/CYP2A6 germline hybrids associated with mutation burden in lung cancer revealed by whole-genome long-read sequencing.
Journal: Scientific reports
Published: April 18, 2025
Evaluation of whole genome sequencing utility in identifying driver alterations in cancer genome.
Journal: Scientific reports
Published: April 30, 2024
Whole-genome and Epigenomic Landscapes of Malignant Gastrointestinal Stromal Tumors Harboring KIT Exon 11 557-558 Deletion Mutations.
Journal: Cancer research communications
Published: September 12, 2022
Development of two 410-cancer-gene panel tests for solid tumors and liquid biopsy based on genome data of 5,143 Japanese cancer patients.
Journal: Biomedical research (Tokyo, Japan)
Published: August 21, 2022
Comparison of genetic susceptibility to lung adenocarcinoma and squamous cell carcinoma in Japanese patients using a novel panel for cancer-related drug-metabolizing enzyme genes.
Journal: Scientific reports
Published: August 01, 2022
BMP4 and PHLDA1 are plausible drug-targetable candidate genes for KRAS G12A-, G12D-, and G12V-driven colorectal cancer.
Journal: Molecular and cellular biochemistry
Published: September 14, 2020
Whole exome sequencing detects variants of genes that mediate response to anticancer drugs.
Journal: The Journal of toxicological sciences
Published: March 22, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026